Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia

NCT00244192 is registered in ClinicalTrials.gov with Center for Integrated Rehabilitation and Organ Failure Horn as lead sponsor.

NCT NCT00244192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00244192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia
Lead sponsor
Center for Integrated Rehabilitation and Organ Failure Horn
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2003
Completion date
December 31, 2005
Enrollment
16
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cachexia, copd